From 1 January 2026, medical devices will have to be prescribed electronically. The traditional paper form will remain valid only in a very limited number of exceptional cases. Prescribers, dispensers, and their IT system providers now have six months to ensure proper implementation.

Ethanol – an ubiquitous alcohol used safely for decades – is a key ingredient in many healthcare, hygiene, and cosmetic products, valued for its proven properties. It has well-documented antimicrobial effects and works as an effective solvent for a broad range of active substances. In biocidal products, ethanol is also a crucial active ingredient with a long use history.

The Chamber of Deputies has successfully passed an important amendment to the Public Health Insurance Act, introducing a wide range of changes across various areas. Some of the proposals sparked controversy, with several ultimately being rejected by lawmakers.

Act No. 375/2022 Coll., on MDs and IVDs, stipulates that distributors and service providers listed in the Information System of Medical Devices (ISZP) must submit a change notification or confirm the accuracy of their data at least once a year—provided no changes occurred during the year. Otherwise, their activity in IZSP will be invalidated. Since ISZP has been launched in early March 2024, the first deadline to confirm data accuracy came at the beginning of last month.

Since 2017, when the Constitutional Court issued a groundbreaking ruling overturning previous regulations on reimbursable medical devices prescribed by voucher, experts have been discussing the urgent need for a new legislative framework governing the inclusion of separately billed material (ZUM) in public health insurance reimbursements. In the interim, VZP has developed a relatively transparent methodology designed to temporarily bridge the gaps in the inadequate legal fram

Subcommittee on Drug Policy, Medical Equipment, and Medical Devices hosted a roundtable discussion on VAT rates for IVD.

The EU is introducing new battery requirements under Regulation (EU) 2023/1542, including those used in medical devices.

An amendment to the Prices Act came into force, which fundamentally changes the procedural rules of the price regulation of MDs.

The Czech Standardization Agency & Porta Medica published "Transition Guide to the MDR" that explains key changes in the MD regulation.

Certain entities will be subject to new obligations under Regulation (EU) 2023/1115.